Publication | Open Access
Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial
80
Citations
34
References
2024
Year
Gastrointestinal OncologyMedicineImmunologyPathologyColorectal CancerImmune Checkpoint InhibitorCancer TreatmentPhase 2OncologyRadiation OncologyMolecular OncologyNeoadjuvant Nivolumab
| Year | Citations | |
|---|---|---|
Page 1
Page 1